Meeting
2020 ASCO Virtual Scientific Program
Assessment and management of cardiovascular risk factors among U.S. Veterans with newly diagnosed prostate cancer.
Authors
Lova Sun
UPHS, Philadelphia, PA
Lova Sun , Ravi Bharat Parikh , Kyle William Robinson , Samuel U Takvorian , David J. Vaughn , Vivek Narayan , Bonnie Ky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5510)
DOI
10.1200/JCO.2020.38.15_suppl.5510
Abstract #
5510
Poster Bd #
91
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Predicting absolute benefit in risk of metastasis of androgen deprivation therapy added to radiation therapy in patients with newly diagnosed prostate cancer using Prolaris.
First Author: Jonathan David Tward
Poster
2024 ASCO Genitourinary Cancers Symposium
Racial and ethnic differences in the receipt of metabolic syndrome risk factor screening and treatment among individuals with prostate cancer treated with androgen deprivation therapy.
First Author: Yazan K. Barqawi
Poster
2023 ASCO Annual Meeting
Assessing racial differences in time to treatment escalation following androgen-deprivation therapy among veterans with prostate cancer.
First Author: Nadine Adriana Friedrich
Poster
2023 ASCO Annual Meeting
Exercise to enhance cardiovascular health among Black patients with prostate cancer with androgen deprivation therapy: The POWER trial.
First Author: Dong-Woo Kang